Stocks News

LAST PRICE
17.6600
TODAY'S CHANGE (%)
Trending Up0.4600 (2.6744%)

Bid / Lots
17.7000/ 3
Ask / Lots
17.8100/ 3
Open / Previous Close
17.1000 / 17.2000
Day Range
Low 17.1000
High 17.9658
52 Week Range
Low 14.1500
High 32.5900
Volume
1,533,672
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Yesterday
- DJ ACADIA Pharmaceuticals Price Target Maintained With a $28.00/Share by Needham, from 8:12AM ET on Thursday Nov 07, 2024 by Dow Jones
  8:12AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: ACAD
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ACAD/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 07, 2024 08:12 ET (13:12 GMT)
- DJ ACADIA Pharmaceuticals Price Target Maintained With a $27.00/Share by HC Wainwright & Co., from 7:48AM ET on Thursday Nov 07, 2024 by Dow Jones
  7:48AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: ACAD
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ACAD/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 07, 2024 07:48 ET (12:48 GMT)
Nov 6, 2024
- -- Earnings Flash (ACAD) ACADIA PHARMACEUTICALS Reports Q3 Revenue $250.4M, from 4:06PM ET on Wednesday Nov 06, 2024 by MT Newswires
  4:06PM ET on Wednesday Nov 06, 2024 by MT Newswires
  Companies Mentioned: ACAD
  04:06 PM EST, 11/06/2024 (MT Newswires) -- ...
Nov 5, 2024
- Acadia Pharmaceuticals to Sell Priority Review Voucher for $150 Million, from 5:32PM ET on Tuesday Nov 05, 2024 by MT Newswires
  5:32PM ET on Tuesday Nov 05, 2024 by MT Newswires
  Companies Mentioned: ACAD
  05:32 PM EST, 11/05/2024 (MT Newswires) -- Acadia Pharmaceuticals (ACAD) said late Tuesday it has struck a deal to sell its rare pediatric disease priority review voucher for $150 million. Acadia said it was granted the voucher in March 2023 followi...
- DJ Acadia Pharmaceuticals to Sell Rare Pediatric Disease Priority Review Voucher, from 5:19PM ET on Tuesday Nov 05, 2024 by Dow Jones
  5:19PM ET on Tuesday Nov 05, 2024 by Dow Jones
  Companies Mentioned: ACAD
  
  By Sabela Ojea
  
  Acadia Pharmaceuticals said it is selling its rare pediatric disease priority review voucher for $150 million.
  
  The biotechnology company on Tuesday said it plans to invest the proceeds from the sale toward research and development programs in central nervous system and rare diseases.

Today
- DJ Veracyte Is Maintained at Sector Outperform by Scotiabank, from 10 hours ago by Dow Jones
  10 hours ago by Dow Jones
  Companies Mentioned: VCYT
- DJ Catalyst Pharmaceuticals Price Target Maintained With a $30.00/Share by HC Wainwright & Co., from 11 hours ago by Dow Jones
  11 hours ago by Dow Jones
  Companies Mentioned: CPRX
Yesterday
- DJ Amicus Therapeutics Is Maintained at Buy by Guggenheim, from 2:34PM ET on Thursday Nov 07, 2024 by Dow Jones
  2:34PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: FOLD
- DJ Veracyte Is Maintained at Buy by Goldman Sachs, from 12:03PM ET on Thursday Nov 07, 2024 by Dow Jones
  12:03PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: VCYT
- DJ Veracyte Is Maintained at Buy by UBS, from 11:28AM ET on Thursday Nov 07, 2024 by Dow Jones
  11:28AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: VCYT
- UBS Adjusts Price Target on Veracyte to $46 From $43, Maintains Buy Rating, from 11:00AM ET on Thursday Nov 07, 2024 by MT Newswires
  11:00AM ET on Thursday Nov 07, 2024 by MT Newswires
  Companies Mentioned: VCYT
- DJ Amicus Therapeutics Is Maintained at Overweight by Cantor Fitzgerald, from 10:53AM ET on Thursday Nov 07, 2024 by Dow Jones
  10:53AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: FOLD
- DJ Veracyte Is Maintained at Buy by Needham, from 5:59AM ET on Thursday Nov 07, 2024 by Dow Jones
  5:59AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: VCYT
Nov 6, 2024
- -- Earnings Flash (VCYT) VERACYTE Posts Q3 Revenue $115.9M, from 4:18PM ET on Wednesday Nov 06, 2024 by MT Newswires
  4:18PM ET on Wednesday Nov 06, 2024 by MT Newswires
  Companies Mentioned: VCYT
- -- Earnings Flash (VCYT) VERACYTE Reports Q3 EPS $0.33, from 4:18PM ET on Wednesday Nov 06, 2024 by MT Newswires
  4:18PM ET on Wednesday Nov 06, 2024 by MT Newswires
  Companies Mentioned: VCYT

ACADIA Pharmaceuticals Inc
NASDAQ:ACADUnited States

Search Criteria

Yesterday

DJ ACADIA Pharmaceuticals Price Target Maintained With a $28.00/Share by Needham, from 8:12AM ET on Thursday Nov 07, 2024 by Dow Jones

DJ ACADIA Pharmaceuticals Price Target Maintained With a $27.00/Share by HC Wainwright & Co., from 7:48AM ET on Thursday Nov 07, 2024 by Dow Jones

Nov 6, 2024

-- Earnings Flash (ACAD) ACADIA PHARMACEUTICALS Reports Q3 Revenue $250.4M, from 4:06PM ET on Wednesday Nov 06, 2024 by MT Newswires

Nov 5, 2024

Acadia Pharmaceuticals to Sell Priority Review Voucher for $150 Million, from 5:32PM ET on Tuesday Nov 05, 2024 by MT Newswires

DJ Acadia Pharmaceuticals to Sell Rare Pediatric Disease Priority Review Voucher, from 5:19PM ET on Tuesday Nov 05, 2024 by Dow Jones

Peers Headlines

Today

DJ Veracyte Is Maintained at Sector Outperform by Scotiabank, from 10 hours ago by Dow Jones

DJ Catalyst Pharmaceuticals Price Target Maintained With a $30.00/Share by HC Wainwright & Co., from 11 hours ago by Dow Jones

Yesterday

DJ Amicus Therapeutics Is Maintained at Buy by Guggenheim, from 2:34PM ET on Thursday Nov 07, 2024 by Dow Jones

DJ Veracyte Is Maintained at Buy by Goldman Sachs, from 12:03PM ET on Thursday Nov 07, 2024 by Dow Jones

DJ Veracyte Is Maintained at Buy by UBS, from 11:28AM ET on Thursday Nov 07, 2024 by Dow Jones

UBS Adjusts Price Target on Veracyte to $46 From $43, Maintains Buy Rating, from 11:00AM ET on Thursday Nov 07, 2024 by MT Newswires

DJ Amicus Therapeutics Is Maintained at Overweight by Cantor Fitzgerald, from 10:53AM ET on Thursday Nov 07, 2024 by Dow Jones

DJ Veracyte Is Maintained at Buy by Needham, from 5:59AM ET on Thursday Nov 07, 2024 by Dow Jones

Nov 6, 2024

-- Earnings Flash (VCYT) VERACYTE Posts Q3 Revenue $115.9M, from 4:18PM ET on Wednesday Nov 06, 2024 by MT Newswires

-- Earnings Flash (VCYT) VERACYTE Reports Q3 EPS $0.33, from 4:18PM ET on Wednesday Nov 06, 2024 by MT Newswires